Pangaea Oncology S.A. (MC:PANG) — Stock Price

€1.43 EUR
▲ 0.00% today

Pangaea Oncology S.A. (MC:PANG) is currently trading at €1.43 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €1.43 and €1.75. This page tracks Pangaea Oncology S.A.'s live share price on the MC exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Pangaea Oncology S.A. (PANG) cash flow conversion.

Pangaea Oncology S.A. (PANG) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pangaea Oncology S.A.'s daily closing share price and trading volume on the MC exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pangaea Oncology S.A. Income Statement — Revenue, Profit & Earnings by Year

Pangaea Oncology S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €14.52 Million €14.27 Million €8.00 Million €4.37 Million €4.60 Million
Cost of Revenue €103.97K €-21.02K €244.86K €255.54K €-568.61K
Gross Profit €14.42 Million €14.29 Million €7.75 Million €4.11 Million €5.17 Million
Research & Development — — €1.03 Million — —
SG&A €4.49 Million €4.07 Million €9.17 Million €1.21 Million €761.39K
Total Operating Expenses €18.06 Million €12.23 Million €10.50 Million €6.31 Million €5.47 Million
Operating Income €-3.64 Million €2.06 Million €-2.74 Million €2.56 Million €-532.97K
EBITDA €-945.65K €1.19 Million €-1.56 Million €-1.41 Million €146.78K
EBIT €-3.73 Million €-1.39 Million €-3.37 Million €-2.65 Million €-845.50K
Interest Expense €298.26K €301.31K €133.94K €189.41K €252.91K
Income Before Tax €-4.02 Million €-1.69 Million €-3.51 Million €-2.84 Million €-1.10 Million
Income Tax Expense €-456.31K €-495.65K €1.29 Million €-114.71K €-456.51K
Net Income €-3.60 Million €-1.17 Million €-4.66 Million €-2.71 Million €-641.91K

Pangaea Oncology S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pangaea Oncology S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €32.11 Million €32.41 Million €28.83 Million €28.38 Million €20.85 Million
Total Current Assets €12.87 Million €13.12 Million €9.63 Million €13.31 Million €7.52 Million
Cash & Equivalents — — — €7.10 Million €2.02 Million
Short-term Investments €1.10 Million €1.10 Million €1.41 Million €1.41 Million €911.32K
Net Receivables €8.72 Million €7.68 Million €6.03 Million €3.66 Million €3.60 Million
Inventory €247.36K €270.64K €283.02K €234.71K €400.76K
Property, Plant & Equipment — — — €352.52K €429.41K
Goodwill €2.19 Million €2.47 Million €3.78 Million €598.84K €48.79K
Total Liabilities €10.05 Million €9.57 Million €10.03 Million €5.30 Million €6.76 Million
Total Current Liabilities €7.25 Million €7.01 Million €7.17 Million €2.72 Million €3.18 Million
Long-term Debt €2.17 Million €1.71 Million €1.86 Million €1.23 Million €1.93 Million
Net Debt €3.85 Million €2.27 Million €4.35 Million €-3.61 Million €3.34 Million
Total Stockholder Equity €21.30 Million €22.10 Million €17.82 Million €23.08 Million €14.09 Million
Retained Earnings €-17.88 Million €-13.32 Million €-11.83 Million €-7.85 Million €-4.49 Million

Pangaea Oncology S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pangaea Oncology S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-2.52 Million €-4.57 Million €-2.40 Million €-3.68 Million €-2.50 Million
Capital Expenditures €472.49K €519.88K €291.36K €20.09K €29.67K
Free Cash Flow €-2.99 Million €-5.08 Million €-2.69 Million €-3.70 Million €-2.53 Million
Investing Cash Flow €-443.17K €-274.64K €-1.58 Million €-745.57K €-797.48K
Financing Cash Flow €1.60 Million €6.79 Million €-1.74 Million €9.50 Million €5.08 Million
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation €2.78 Million €2.58 Million €1.82 Million €1.24 Million €992.28K
Change in Cash €-1.36 Million €1.95 Million €-5.72 Million €5.08 Million €1.77 Million

Pangaea Oncology S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track Pangaea Oncology S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Pangaea Oncology S.A..